Citation APA
Campani, C., Galvanin, C., Shim, J. H., Bouattour, M., Touchefeu, Y., Delhoume, V., Rosmorduc, O., Pascale, A., An, J., Lee, H. C., Regnault, H., Thabut, D., Paradis, V., Calderaro, J., Ziol, M., Beaufrère, A., Sayadi, A., Amaddeo, G., Allaire, M., Olivier-Hourmand, I., Metivier, C., Rondini, E., Ronot, M., Ntandja-Wandji, L., Ozenne, V., Sidali, S., Marra, F., Hollande, C., Ganne-Carrié, N., Nahon, P., Lequoy, M., Sharma, R., Paris Liver Cancer Group,, Ningarahi, M., Trepo, E., & Nault, J. C. (2025). The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab. Clinical gastroenterology and hepatology. doi:10.1016/j.cgh.2025.11.018
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/401810